Literature DB >> 1269153

Dopamine-beta-hydroxylase activity in serum following acute myocardial infarction: an evaluation of this parameter for routine use as an index of sympathetic activity.

T Gutteberg, O Borud, J H Stromme.   

Abstract

Dopamine-beta-hydroxylase activity was measured in sera from 114 normal males and from 11 patients on the 1st, 2nd, 3rd, 5th and 10th day following acute myocardial infarction. A significant elevation of dopamine-beta-hydroxylase levels (P less than 0.001) was found during the first two days after infarction when compared with the 10th-day values. Only a few activities were above the reference range. Temporary elevations of glucose and glycerol levels were also found. Assay of serum dopamine-beta-hydroxylase may be a useful parameter of sympathetic activity in longitudinal studies in which each individual is used as his own reference.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1269153     DOI： 10.1016/0009-8981(76)90471-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  5 in total

1.  Changes of dopamine beta-hydroxylase activity in human plasma during prolonged overactivity of the sympathetic nervous system in various diseases.

Authors:  H Hörtnagl; R Stadler-Wolffersgrün; T h Brücke; A F Hammerle; J M Hackl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

2.  Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.

Authors:  C R Benedict; D G Grahame-Smith
Journal:  Br Heart J       Date:  1979-08

3.  Dopamine-beta-hydroxylase in patients with cystic fibrosis.

Authors:  M H Schöni; K Türler; H Käser; R Kraemer
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

4.  Changes in plasma dopamine-beta-hydroxylase activity during the perioperative period of cardiac surgery: an index of sympathetic nerve activity.

Authors:  M Yoshizumi; I Katoh; Y Egawa; T Kitagawa; O Miki; Y Masuda; T Ohuchi; M Oka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Intravenous atenolol in elderly patients in the early phase of acute myocardial infarction.

Authors:  Z S Kyriakides; D Kremastinos; G Karavolias; C Papadopoulos; T Apostolou; J Paraskevaidis; P Toutouzas
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.